Beijing SL Pharmaceutical Co., Ltd. (SZSE:002038) agreed to acquire remaining 30% stake in Xinxiang SL Pharmaceutical Co., Ltd. from Xinxiang Chemical Fiber Co., Ltd. (SZSE:000949) for CNY 10.8 million on October 28, 2022. As on September 30, 2022, Xinxiang SL Pharmaceutical Co., Ltd. generated total assets of CNY 37.9 million and net assets of CNY 35.2 million. The transaction is approved by board of directors of Xinxiang Chemical Fiber Co., Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.31 CNY | +0.97% | +0.12% | -18.45% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-18.45% | 1.18B | |
+25.46% | 659B | |
+26.69% | 557B | |
-4.86% | 359B | |
+16.44% | 322B | |
+8.34% | 297B | |
+6.53% | 215B | |
+7.58% | 210B | |
-6.30% | 200B | |
-8.79% | 149B |
- Stock Market
- Equities
- 002038 Stock
- News Beijing SL Pharmaceutical Co., Ltd.
- Beijing SL Pharmaceutical Co., Ltd. agreed to acquire remaining 30% stake in Xinxiang SL Pharmaceutical Co., Ltd. from Xinxiang Chemical Fiber Co., Ltd. for CNY 10.8 million.